United States · FDA National Drug Code directory
Quillivant XR
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 24478-324_b013d8b4-c598-45d9-9934-51fca4539a24
- Product NDC
- 24478-324
- Form
- SUSPENSION, EXTENDED RELEASE
- Composition / generic term
- methylphenidate hydrochloride
- Labeler
- NextWave Pharmaceuticals, Inc
- Marketing category
- NDA
- Marketing start / end (source format)
- 20130104
- Source listing expiry
- 20271231
Source-listed ingredients
- METHYLPHENIDATE HYDROCHLORIDE — 900 mg/180mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (24478-324-06) / 180 mL in 1 BOTTLE · 24478-324-06
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →